Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Niagen Bioscience Inc

    NASDAQ: NAGE · Real-Time Price · USD
    14.20
    0.38 (2.75%)
    At close: Jun 27, 2025, 3:59 PM
    13.98
    -1.55%
    After-hours: Jun 27, 2025, 05:14 PM EDT

    Niagen Bioscience Inc Statistics

    Share Statistics

    Niagen Bioscience Inc has 78.77M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 78.77M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 150

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 2.8M, so 3.56% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.8M

    Short % of Shares Out

    n/a
    		 3.56%

    Short % of Float

    n/a
    		 5.41%

    Short Ratio (days to cover)

    n/a
    		 3.32

    Valuation Ratios

    The PE ratio is 53.05 and the forward PE ratio is 56. Niagen Bioscience Inc's PEG ratio is -0.22.

    PE Ratio

    n/a
    		 53.05

    Forward PE

    n/a
    		 56

    PS Ratio

    n/a
    		 4.55

    Forward PS

    n/a
    		 6.1

    PB Ratio

    n/a
    		 9.84

    P/FCF Ratio

    n/a
    		 37.97

    PEG Ratio

    n/a
    		 -0.22
    Financial Ratio History

    Enterprise Valuation

    Niagen Bioscience Inc has an Enterprise Value (EV) of 411.74M.

    EV / Sales

    n/a
    		 4.13

    EV / EBITDA

    n/a
    		 44.71

    EV / EBIT

    n/a
    		 34

    EV / FCF

    n/a
    		 34.47

    Financial Position

    The company has a current ratio of 3.57, with a Debt / Equity ratio of 0.06.

    Current Ratio

    n/a
    		 3.57

    Quick Ratio

    n/a
    		 3.06

    Debt / Equity

    n/a
    		 0.06

    Debt / EBITDA

    n/a
    		 0.29

    Debt / FCF

    n/a
    		 0.22

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 18.55% and Return on Invested Capital is 14.53%.

    Return on Equity

    n/a
    		 18.55%

    Return on Assets

    n/a
    		 12.52%

    Return on Invested Capital

    n/a
    		 14.53%

    Revenue Per Employee

    n/a
    		 $957,663.46

    Profits Per Employee

    n/a
    		 $82,211.54

    Employee Count

    n/a
    		 104

    Asset Turnover

    n/a
    		 1.46

    Inventory Turnover

    n/a
    		 4.14

    Taxes

    Income Tax

    n/a
    		 305K

    Effective Tax Rate

    n/a
    		 3.44%

    Stock Price Statistics

    The stock price has increased by 421.51% in the last 52 weeks. The beta is 2.08, so Niagen Bioscience Inc's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.08

    52-Week Price Change

    n/a
    		 421.51%

    50-Day Moving Average

    n/a
    		 10.44

    200-Day Moving Average

    n/a
    		 6.84

    Relative Strength Index (RSI)

    n/a
    		 64.24

    Average Volume (20 Days)

    n/a
    		 879,675

    Income Statement

    In the last 12 months, Niagen Bioscience Inc had revenue of 99.6M and earned 8.55M in profits. Earnings per share was 0.1.

    Revenue

    n/a
    		 99.6M

    Gross Profit

    n/a
    		 61.59M

    Operating Income

    n/a
    		 7.73M

    Net Income

    n/a
    		 8.55M

    EBITDA

    n/a
    		 9.21M

    EBIT

    n/a
    		 7.73M

    Earnings Per Share (EPS)

    n/a
    		 0.1
    Full Income Statement

    Balance Sheet

    The company has 44.51M in cash and 2.65M in debt, giving a net cash position of 41.86M.

    Cash & Cash Equivalents

    n/a
    		 44.51M

    Total Debt

    n/a
    		 2.65M

    Net Cash

    n/a
    		 41.86M

    Retained Earnings

    n/a
    		 -181.91M

    Total Assets

    n/a
    		 68.28M

    Working Capital

    n/a
    		 46.15M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 12.11M and capital expenditures -163K, giving a free cash flow of 11.95M.

    Operating Cash Flow

    n/a
    		 12.11M

    Capital Expenditures

    n/a
    		 -163K

    Free Cash Flow

    n/a
    		 11.95M

    FCF Per Share

    n/a
    		 0.14
    Full Cash Flow Statement

    Margins

    Gross margin is 61.84%, with operating and profit margins of 7.76% and 8.58%.

    Gross Margin

    n/a
    		 61.84%

    Operating Margin

    n/a
    		 7.76%

    Pretax Margin

    n/a
    		 8.89%

    Profit Margin

    n/a
    		 8.58%

    EBITDA Margin

    n/a
    		 9.25%

    EBIT Margin

    n/a
    		 7.76%

    FCF Margin

    n/a
    		 11.99%

    Dividends & Yields

    NAGE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 1.88%

    FCF Yield

    n/a
    		 2.63%
    Dividend Details

    Analyst Forecast

    The average price target for NAGE is $16, which is 15.8% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $16

    Price Target Difference

    n/a
    		 15.8%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 1.1

    Graham Upside

    n/a
    		 -92.04%

    Stock Splits

    The last stock split was on Apr 13, 2016. It was a backward split with a ratio of 1:3.

    Last Split Date

    n/a
    		 Apr 13, 2016

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:3

    Scores

    Altman Z-Score

    n/a
    		 22.7

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist